10X Genomics, Inc. (TXG)
51.80
-5.58
(-9.72%)
USD |
NASDAQ |
Nov 20, 16:00
50.73
-1.07
(-2.07%)
After-Hours: 20:00
10X Genomics Research and Development Expense (TTM) : 222.54M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 222.54M |
| June 30, 2026 | 226.80M |
| March 31, 2026 | 231.23M |
| December 31, 2025 | 238.63M |
| September 30, 2025 | 249.63M |
| June 30, 2025 | 258.61M |
| March 31, 2025 | 260.30M |
| December 31, 2024 | 264.00M |
| September 30, 2024 | 252.58M |
| June 30, 2024 | 243.54M |
| March 31, 2024 | 242.14M |
| December 31, 2023 | 234.82M |
| September 30, 2023 | 236.36M |
| June 30, 2023 | 240.36M |
| March 31, 2023 | 243.03M |
| December 31, 2022 | 246.49M |
| September 30, 2022 | 251.28M |
| June 30, 2022 | 239.03M |
| Date | Value |
|---|---|
| March 31, 2022 | 223.36M |
| December 31, 2021 | 201.17M |
| September 30, 2021 | 178.99M |
| June 30, 2021 | 160.24M |
| March 31, 2021 | 139.26M |
| December 31, 2020 | 123.37M |
| September 30, 2020 | 111.56M |
| June 30, 2020 | 103.62M |
| March 31, 2020 | 94.12M |
| December 31, 2019 | 83.10M |
| September 30, 2019 | 68.29M |
| June 30, 2019 | 57.16M |
| March 31, 2019 | 50.57M |
| December 31, 2018 | 47.54M |
| September 30, 2018 | 43.99M |
| June 30, 2018 | 40.98M |
| March 31, 2018 | 36.87M |
| December 31, 2017 | 32.16M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 71.84M |
| Tempus AI, Inc. | 373.05M |
| Personalis, Inc. | 60.02M |
| Intellia Therapeutics, Inc. | 326.72M |
| Alamar Biosciences, Inc. (California) | 53.21M |